Inhibition of norovirus binding in a lab setting shows promise for future treatments against foodborne outbreaks.
Porphyra tenera (PT), an edible red alga, is consumed as a health-promoting seaweed. Human norovirus (HuNV), the major cause of foodborne disease outbreaks worldwide, binds to histo-blood group antigens (HBGAs) for cell entry. We investigated the inhibitory activity of fucose-containing polysaccharides in PT on HuNV binding to the HBGAs. With saliva as a source of HBGAs and recombinant P domains of HuNV GII.4 and GII.17 purified as NV antigens, the inhibition and binding affinity of PT toward P domains were evaluated using enzyme-linked immunosorbent assay and bio-layer interferometry, respectively. The PT polysaccharide extract and its 3–10 kDa fraction (F3-10) among molecular weight fractions inhibited the P domain binding to saliva significantly, compared with that of a commercial fucoidan. F3-10 bound directly to the P domains with submicromolar affinities (K D = 5.6 × 10 −7 M for GII.4 and 8.7 × 10 −7 M for GII.17). When applied to virus inhibition assays, F3-10 significantly reduced murine NV titers in a dose-dependent manner; specifically, it showed a 1.8 log 10 plaque forming unit (PFU)/mL reduction at 1 mg/mL in RAW 264.7 cells ( p < 0.05) and a 1.4 log 10 PFU/mL reduction at 5 mg/mL under simulated human digestion conditions involving sequential incubation in simulated saliva, gastric, and intestinal fluids ( p < 0.01). F3-10 contained galactose, glucose, fucose, and xylose as its constituent monosaccharides and also sulfate groups. The PT fraction F3-10 is a promising candidate for further study aimed at inhibiting HuNV binding to host cell HBGAs.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: